NovelStem International Corp. Cash Flow Statement
NSTM|4 years of annual SEC 10-K data (FY2009-FY2012)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 4 fiscal years. All figures from audited SEC 10-K filings.
NovelStem International Corp. used $4M in operating cash flow and negative free cash flow of $4M in FY2012.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -2.54 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|
| Net Income | $10.4M | -$6.9M | $4.9M | -$5.6M |
| Depreciation & Amortization | $136.4K | $203.2K | $541.3K | $744.0K |
| Operating Cash Flow | -$3.9M | -$2.6M | $3.9M | $4.0M |
| Capital Expenditures | $84.0K | $90.3K | $141.7K | $101.6K |
| Free Cash Flow | -$4.0M | -$2.7M | $3.8M | $3.9M |
| Share Buybacks | - | $16.4M | - | - |
| FCF Margin | -649.0% | -251.5% | 94.9% | 85.4% |